Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Gutmann

Showing results (121-130 of 434) with videos related to

Pageof 44
Sort By:
Annals of Neurology|June 28, 2006
The neurobiology of neurooncologyTracy-Ann Read, Balazs Hegedus, Robert Wechsler-Reya, et al.
Molecular and Cellular Biology|December 24, 2008
The neurofibromatosis 2 protein, merlin, regulates glial cell growth in an ErbB2- and Src-dependent mannerS Sean Houshmandi, Ryan J Emnett, Marco Giovannini, et al.
Human Molecular Genetics|March 20, 2015
Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learningCorina Anastasaki, Albert S Woo, Ludwine M Messiaen, et al.
Journal of Child Neurology|November 1, 2012
Longitudinal analysis of developmental delays in children with neurofibromatosis type 1Lauren E Wessel, Feng Gao, David H Gutmann, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 4, 2024
Low-grade glioma in children with neurofibromatosis type 1: surveillance, treatment indications, management, and future directionsChelsea Kotch, Peter de Blank, David H Gutmann, et al.
Glia|February 5, 2009
Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferationTu-Hsueh Yeh, Da Yong Lee, Scott M Gianino, et al.
Case Reports in Medicine|May 2, 2012
Novel BRAF Alteration in a Sporadic Pilocytic AstrocytomaSonika Dahiya, Jinsheng Yu, Aparna Kaul, et al.
Neurology|May 15, 2013
Teaching NeuroImages: T2 hyperintensities in neurofibromatosis type 1Adam P Ostendorf, Robert C McKinstry, Joshua S Shimony, et al.
Expert Opinion on Investigational Drugs|February 22, 2013
Optimizing biologically targeted clinical trials for neurofibromatosisDavid H Gutmann, Jaishri O Blakeley, Bruce R Korf, et al.
Developmental Medicine and Child Neurology|January 20, 2019
Adaptive functioning in children with neurofibromatosis type 1: relationship to cognition, behavior, and magnetic resonance imagingNoah S Eby, Jennifer L Griffith, David H Gutmann, et al.
Pageof 44

Showing results (121-130 of 434) with videos related to

Sort By:
Pageof 44
Annals of Neurology|June 28, 2006
The neurobiology of neurooncologyTracy-Ann Read, Balazs Hegedus, Robert Wechsler-Reya, et al.
Molecular and Cellular Biology|December 24, 2008
The neurofibromatosis 2 protein, merlin, regulates glial cell growth in an ErbB2- and Src-dependent mannerS Sean Houshmandi, Ryan J Emnett, Marco Giovannini, et al.
Human Molecular Genetics|March 20, 2015
Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learningCorina Anastasaki, Albert S Woo, Ludwine M Messiaen, et al.
Journal of Child Neurology|November 1, 2012
Longitudinal analysis of developmental delays in children with neurofibromatosis type 1Lauren E Wessel, Feng Gao, David H Gutmann, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 4, 2024
Low-grade glioma in children with neurofibromatosis type 1: surveillance, treatment indications, management, and future directionsChelsea Kotch, Peter de Blank, David H Gutmann, et al.
Glia|February 5, 2009
Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferationTu-Hsueh Yeh, Da Yong Lee, Scott M Gianino, et al.
Case Reports in Medicine|May 2, 2012
Novel BRAF Alteration in a Sporadic Pilocytic AstrocytomaSonika Dahiya, Jinsheng Yu, Aparna Kaul, et al.
Neurology|May 15, 2013
Teaching NeuroImages: T2 hyperintensities in neurofibromatosis type 1Adam P Ostendorf, Robert C McKinstry, Joshua S Shimony, et al.
Expert Opinion on Investigational Drugs|February 22, 2013
Optimizing biologically targeted clinical trials for neurofibromatosisDavid H Gutmann, Jaishri O Blakeley, Bruce R Korf, et al.
Developmental Medicine and Child Neurology|January 20, 2019
Adaptive functioning in children with neurofibromatosis type 1: relationship to cognition, behavior, and magnetic resonance imagingNoah S Eby, Jennifer L Griffith, David H Gutmann, et al.
Pageof 44